- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Molecular Templates (NASDAQ:MTEM), Quotes and News Summary
Molecular Templates (NASDAQ: MTEM)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-11 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.380 | ||||||
| REV | 8.486M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Molecular Templates Questions & Answers
You can purchase shares of Molecular Templates (NASDAQ: MTEM) through any online brokerage.
Other companies in Molecular Templates’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Lumos Pharma (NASDAQ:LUMO), Genprex (NASDAQ:GNPX), Viracta Therapeutics (NASDAQ:VIRX) and Harpoon Therapeutics (NASDAQ:HARP).
The latest price target for Molecular Templates (NASDAQ: MTEM) was reported by Barclays on Wednesday, March 30, 2022. The analyst firm set a price target for 4.50 expecting MTEM to rise to within 12 months (a possible 289.61% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Molecular Templates (NASDAQ: MTEM) is $1.155 last updated Today at May 16, 2022, 5:37 PM UTC.
There are no upcoming dividends for Molecular Templates.
Molecular Templates’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Molecular Templates.
Molecular Templates is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.